Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00088205
Status:
COMPLETED
Last Update Posted:
2020-07-01
First Post:
2004-07-22
Brief Title:
Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Mantle-Cell Lymphoma |
Keywords: